Share-based Payment Arrangement, Expense of SOLENO THERAPEUTICS INC from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
SOLENO THERAPEUTICS INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • SOLENO THERAPEUTICS INC Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $11,471,000, a 61% decline year-over-year.
  • SOLENO THERAPEUTICS INC Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $45,846,000, a 54% decline year-over-year.
  • SOLENO THERAPEUTICS INC annual Share-based Payment Arrangement, Expense for 2025 was $45,846,000, a 54% decline from 2024.
  • SOLENO THERAPEUTICS INC annual Share-based Payment Arrangement, Expense for 2024 was $99,958,000, a 1581% increase from 2023.
  • SOLENO THERAPEUTICS INC annual Share-based Payment Arrangement, Expense for 2023 was $5,945,000, a 135% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

SOLENO THERAPEUTICS INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $45,846,000 $11,471,000 -$18,284,000 -61% 01 Oct 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 $64,130,000 $9,998,000 -$46,600,000 -82% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $110,730,000 $9,698,000 +$2,538,000 +35% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $108,192,000 $14,679,000 +$8,234,000 +128% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $99,958,000 $29,755,000 +$27,846,000 +1459% 01 Oct 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 $72,112,000 $56,598,000 +$54,397,000 +2471% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 $17,715,000 $7,160,000 +$5,956,000 +495% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $11,759,000 $6,445,000 +$5,814,000 +921% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $5,945,000 $1,909,000 +$1,277,000 +202% 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
Q3 2023 $4,668,000 $2,201,000 +$1,518,000 +222% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $3,150,000 $1,204,000 +$633,000 +111% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $2,517,000 $631,000 -$13,000 -2% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $2,530,000 $632,000 +$214,000 +51% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
Q3 2022 $2,316,000 $683,000 -$223,000 -25% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $2,539,000 $571,000 -$286,000 -33% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $2,825,000 $644,000 -$451,000 -41% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $3,276,000 $418,000 +$25,000 +6.4% 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $3,251,000 $906,000 +$532,000 +142% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $2,719,000 $857,000 +$516,000 +151% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 $2,203,000 $1,095,000 +$703,000 +179% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $1,500,000 $393,000 +$143,000 +57% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $1,357,000 $374,000 +$221,000 +144% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $1,136,000 $341,000 +$121,000 +55% 01 Apr 2020 30 Jun 2020 10-Q 28 Jul 2021 2021 Q2
Q1 2020 $1,015,000 $392,000 +$190,000 +94% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q4 2019 $825,000 $250,000 -$261,000 -51% 01 Oct 2019 31 Dec 2019 10-K 03 Mar 2021 2020 FY
Q3 2019 $1,086,000 $153,000 -$78,000 -34% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $1,164,000 $220,000 +$21,000 +11% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $1,143,000 $202,000 -$157,000 -44% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q4 2018 $1,300,000 $511,000 +$365,000 +250% 01 Oct 2018 31 Dec 2018 10-K 04 Mar 2020 2019 FY
Q3 2018 $935,000 $231,000 +$5,000 +2.2% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2019 Q3
Q2 2018 $930,000 $199,000 -$244,000 -55% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $1,174,000 $359,000 +$174,000 +94% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
Q4 2017 $1,000,000 $146,000 -$165,270 -53% 01 Oct 2017 31 Dec 2017 10-K 20 Mar 2019 2018 FY
Q3 2017 $1,165,270 $226,000 +$20,000 +9.7% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $1,145,270 $443,000 +$225,000 +103% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $920,270 $185,000 +$49,000 +36% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q4 2016 $871,270 $311,270 +$114,901 +59% 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 $756,369 $206,000 +$62,000 +43% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $694,369 $218,000 +$17,000 +8.5% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017 2017 Q2
Q1 2016 $677,369 $136,000 -$265,000 -66% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1
Q4 2015 $942,369 $196,369 -$128,066 -39% 01 Oct 2015 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q3 2015 $1,070,435 $144,000 +$139,000 +2780% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 $931,435 $201,000 +$196,000 +3920% 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2016 2016 Q2
Q1 2015 $735,435 $401,000 +$390,000 +3545% 01 Jan 2015 31 Mar 2015 10-Q 09 Aug 2016 2016 Q1
Q4 2014 $345,435 $324,435 01 Oct 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
Q3 2014 $5,000 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015 2015 Q3
Q2 2014 $5,000 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015 2015 Q2
Q1 2014 $11,000 01 Jan 2014 31 Mar 2014 10-Q 04 May 2015 2015 Q1

SOLENO THERAPEUTICS INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $45,846,000 -$54,112,000 -54% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $99,958,000 +$94,013,000 +1581% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $5,945,000 +$3,415,000 +135% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $2,530,000 -$746,000 -23% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $3,276,000 +$1,776,000 +118% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
2020 $1,500,000 +$675,000 +82% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $825,000 -$475,000 -37% 01 Jan 2019 31 Dec 2019 10-K 03 Mar 2021 2020 FY
2018 $1,300,000 +$300,000 +30% 01 Jan 2018 31 Dec 2018 10-K 04 Mar 2020 2019 FY
2017 $1,000,000 +$128,730 +15% 01 Jan 2017 31 Dec 2017 10-K 20 Mar 2019 2018 FY
2016 $871,270 -$71,099 -7.5% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 $942,369 +$596,934 +173% 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2017 2016 FY
2014 $345,435 +$307,018 +799% 01 Jan 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
2013 $38,417 01 Jan 2013 31 Dec 2013 10-K 13 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.